Advertisement

Index by author

April 01, 1985; Volume 27,Issue 4

A

  1. Adams, A

    1. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
      A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
      Molecular Pharmacology April 1985, 27 (4) 480-491;

  2. Allen, D T

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

  3. Avbelj, F

    1. Potential energy functions and the role of the conformational entropy of clonidine-like imidazolidines in determining their affinity for alpha-adrenergic receptors.
      F Avbelj and D Hadzi
      Molecular Pharmacology April 1985, 27 (4) 466-470;

B

  1. Bock, K W

    1. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.
      W Lilienblum, B S Bock-Hennig and K W Bock
      Molecular Pharmacology April 1985, 27 (4) 451-458;

  2. Bock-Hennig, B S

    1. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.
      W Lilienblum, B S Bock-Hennig and K W Bock
      Molecular Pharmacology April 1985, 27 (4) 451-458;

D

  1. Denny, W A

    1. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
      A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
      Molecular Pharmacology April 1985, 27 (4) 480-491;

E

  1. Elmes, B C

    1. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
      A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
      Molecular Pharmacology April 1985, 27 (4) 480-491;

G

  1. Gustafsson, J A

    1. Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.
      E T Morgan, C MacGeoch and J A Gustafsson
      Molecular Pharmacology April 1985, 27 (4) 471-479;

H

  1. Hadzi, D

    1. Potential energy functions and the role of the conformational entropy of clonidine-like imidazolidines in determining their affinity for alpha-adrenergic receptors.
      F Avbelj and D Hadzi
      Molecular Pharmacology April 1985, 27 (4) 466-470;

  2. Howlett, A C

    1. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.
      A C Howlett
      Molecular Pharmacology April 1985, 27 (4) 429-436;

J

  1. Jarrott, B

    1. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
      A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
      Molecular Pharmacology April 1985, 27 (4) 480-491;

  2. Johnston, C T

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

K

  1. Kloog, Y

    1. Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.
      Y Kloog and M Sokolovsky
      Molecular Pharmacology April 1985, 27 (4) 418-428;

L

  1. Lilienblum, W

    1. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.
      W Lilienblum, B S Bock-Hennig and K W Bock
      Molecular Pharmacology April 1985, 27 (4) 451-458;

M

  1. MacGeoch, C

    1. Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.
      E T Morgan, C MacGeoch and J A Gustafsson
      Molecular Pharmacology April 1985, 27 (4) 471-479;

  2. Marks, G S

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

  3. McGee, R

    1. Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
      D Robinson and R McGee
      Molecular Pharmacology April 1985, 27 (4) 409-417;

  4. Morgan, E T

    1. Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.
      E T Morgan, C MacGeoch and J A Gustafsson
      Molecular Pharmacology April 1985, 27 (4) 471-479;

N

  1. Nakatsu, K

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

P

  1. Page, J D

    1. Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
      J D Page, I B Wilson and I Silman
      Molecular Pharmacology April 1985, 27 (4) 437-443;

R

  1. Raess, B U

    1. Interaction of phenylglyoxal with the human erythrocyte (Ca2+ + Mg2+)-ATPase. Evidence for the presence of an essential arginyl residue.
      B U Raess, D M Record and G Tunnicliff
      Molecular Pharmacology April 1985, 27 (4) 444-450;

  2. Record, D M

    1. Interaction of phenylglyoxal with the human erythrocyte (Ca2+ + Mg2+)-ATPase. Evidence for the presence of an essential arginyl residue.
      B U Raess, D M Record and G Tunnicliff
      Molecular Pharmacology April 1985, 27 (4) 444-450;

  3. Robinson, D

    1. Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
      D Robinson and R McGee
      Molecular Pharmacology April 1985, 27 (4) 409-417;

S

  1. Silman, I

    1. Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
      J D Page, I B Wilson and I Silman
      Molecular Pharmacology April 1985, 27 (4) 437-443;

  2. Sokolovsky, M

    1. Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.
      Y Kloog and M Sokolovsky
      Molecular Pharmacology April 1985, 27 (4) 418-428;

  3. Sutherland, E P

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

T

  1. Tunnicliff, G

    1. Interaction of phenylglyoxal with the human erythrocyte (Ca2+ + Mg2+)-ATPase. Evidence for the presence of an essential arginyl residue.
      B U Raess, D M Record and G Tunnicliff
      Molecular Pharmacology April 1985, 27 (4) 444-450;

W

  1. Wakelin, L P

    1. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
      A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
      Molecular Pharmacology April 1985, 27 (4) 480-491;

  2. Whitney, R A

    1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
      G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
      Molecular Pharmacology April 1985, 27 (4) 459-465;

  3. Wilson, I B

    1. Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
      J D Page, I B Wilson and I Silman
      Molecular Pharmacology April 1985, 27 (4) 437-443;
Back to top

In this issue

Advertisement